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Background: Complementary and alternative medicine (CAM) may offer benefits as well as risks to people with
cardiovascular disease. Understanding the prevalence and the nature of CAM use will encourage beneficial CAM
therapies, prevent potential herb-drug interactions and foster communication between patients and physicians.
Methods: A systematic search of eight bibliographic databases was conducted for studies that investigated CAM
use in patients with cardiovascular diseases. Two independent reviewers selected relevant abstracts and evaluated
the quality of included studies.
Results: Twenty-seven studies were included. Prevalence of CAM use in cardiac patients ranged from 4% - 61%.
Biologically-based therapies usage ranged from 22% to 68%. Herbal medicines were used by between 2% and 46%.
A large proportion of patients did not inform medical practitioners about their CAM use and up to 90% of treating
physicians did not discuss CAM use with their patients.
Conclusions: CAM use in patients with cardiovascular disease appears common. The findings suggest that the
effects of CAM on medical management of cardiovascular disease may be overlooked and that patient-physician
communication need to be strengthened.Background
Cardiovascular disease (CVD) is the leading cause of mor-
bidity and mortality in Australia. CVD affects four million
Australians and accounted for 38% of all deaths in 2004
[1]. Around 62% of people with CVD take medication for
their condition, and given the chronic nature of CVD, this
is an important part of long-term management. Effective
medical management of CVD may be compromised by in-
appropriate use of complementary and alternative medi-
cine (CAM). CAM use is estimated at between 9% and
65% globally [2]. In Australia, one in two people regularly
use CAM, and consumers spend more money on CAM
than prescription drugs [3].
The Australian Therapeutic Goods Administration
(TGA) defines complementary medicine as medicines con-
taining herbs, vitamins, minerals, nutritional supplements,* Correspondence: d.chang@uws.edu.au
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reproduction in any medium, provided the orhomoeopathic medicines and certain aromatherapy pro-
ducts [4]. The TGA’s definition does not cover some im-
portant non-ingestible CAM modalities such as
osteopathy, massage, reiki, qigong, yoga and meditation.
These modalities are included in a more comprehensive
definition from the US National Centre for Complemen-
tary Medicine and Alternative Medicine (NCCAM) [5].
In cardiac patients, the use of CAM offers both risks
and benefits. For instance, physical therapies such as qi-
gong appear helpful for hypertension while coenzyme
Q10 supplements have favourable effects in those with
heart failure [6,7]. Biological therapies such as dietary
supplements and herbal medicine may interfere with
the action of prescription medications, a potentially
harmful consequence. Herb-drug interactions are of
concern in cardiac patients because of the narrow thera-
peutic window and range of cardiac medications. People
with chronic diseases frequently use CAM therapies to
manage their condition, and thus increase exposure to
herb-drug interactions [8]. It is therefore important to
understand the prevalence and the nature of CAM usetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Databases, MeSH keywords, and qualifiers used in the search strategy
Database
From inception – 20 April 2010
Search terms
AMED MeSH: ‘cardiovascular diseases’ [exploded] AND (‘complementary therapies’
[exploded] OR ‘dietary supplements[exploded] OR ‘plants, medicinal’
[exploded] AND ‘data collection’ [exploded] Where MeSH terms
were unavailable, the following terms were combined: [complementary medicine$
or complementary therapy$ or alternative medicine$” or “supplement$ or herb$ or
homeopath$ or osteopath$ or acupuncture or Chinese medicine$ or mind-body
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therapies and to prevent potential herb-drug interac-
tions. In the current study, we conducted a systematic
review of the literature to determine the prevalence of
CAM use by cardiac patients.Table 2 Quality Assessment of Studies












Report efforts to address nonresponsive
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Adjust for
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Response rate Where response rate = (no. of participan
the study/No of people invited to take p
Representative
sampling strategy
Any attempt to a representative sample
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PARTICIPANT’S CHARACTERISTICS
Specific diagnosis Report participants’ diagnoses
Indicator of socioeconomic status Report participants’ socioeconomic statu
Age Report participants’ ages
Ethnicity Report participants’ ethnicity
Gender Report participants’ gender
CAM USAGE
CAM definition Information about the definition of CAM
list of CAM modalities provided to partic
Use of CAM
modalities assessed




Report how often or for what duration t
CAM were/are used by study participant
Reasons for CAM use Report the reasons for the use of
CAM by study participantsMethods
Literature search strategy
We searched eight databases for articles published in
peer-reviewed journals that reported primary data on the
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Table 1. The period of the search was from the inception
of each database until 20 April 2010.
Studies were included if they reported the prevalence
of CAM use in patients either attending for cardiac care
or reporting a cardiovascular condition. If abstracts were
unavailable or unclear, the full-text article was retrieved.
Studies were excluded where the (i) study methods were
not described, (ii) data on participants with cardiovascu-
lar disease could not be separated from other study
populations, or (iii) the study was not in English. Refer-
ence lists were manually searched to locate articles not
found by the above methods. Two independent
reviewers (Grant and Chang) examined titles and
abstracts of the articles for inclusion or exclusion. Dis-
agreements were resolved by reviewing the full papers
and discussion. Data was extracted according to a prede-
fined format covering the study methodology (Table 2),
participant demographics, and CAM use (Table 3).
Quality assessment
There is a paucity of methods for assessing the quality of
observational studies [36,37]. Bishop et al. (2010) re-
cently developed a Quality Assessment Tool (QAT) for a
systematic review of the prevalence of complementary
medicine use in paediatric cancer based on the princi-
ples of the STROBE statement [38]. We used a modified
version of the QAT in the present review (Table 2). Like
Bishop et al. (2010), we weighted these items according
to their respective significance through consensus of the
authors [38] and the two independent reviewers assessed
each study using the QAT, with disagreements resolved
by discussion.
Statistical analyses
There are two methods commonly used to summarise
prevalence rates across observational studies: variations in
frequency estimates can be displayed graphically or sum-
marized with quantiles around measures of central ten-
dency [39].We chose to display the results graphically
with no meta-analysis due to the variation in definitions of
CAM and the heterogeneous methodologies of the
included studies.
Results
Our database search found 2,124 articles, of which 112
full-text articles were retrieved. Three studies were identi-
fied that utilised the same dataset of the 2002 USA Na-
tional Health Interview Survey [12,40,41]. We included
only Yeh et al. [12] which covered the cohorts of the other
two studies. In total the search identified 27 studies suit-
able for inclusion in our review (Table 3). All were cross-
sectional studies.Study characteristics
Scope
The bulk of the studies looked at CAM use in general.
Three of these utilised the National Institute of Health’s
defined categories of CAM [12-14], while eight studies
provided comprehensive yet differing definitions of
CAM [9,15-20,33]. Two studies did not define CAM but
used open-ended questions to elicit the CAM therapies
utilised [21,34]. Thirteen studies looked specifically at
biological-based therapies, such as vitamins, minerals
and dietary supplements [10,22-26], herbal medicine only
[27,28] or a combination of both [29-31,35] and one study
reported on the use of chelation therapy following angio-
plasty [11]. The remaining study looked specifically at
mind-body therapy [32].
Most studies reported on CAM prevalence in a cohort
of people with cardiovascular disease although some
reported on a specific diagnosis. Two studies reported
on CAM use in people with stroke [17,23], five on
chronic heart failure [21,26,29,30,35] and four examined
CAM prevalence in people with hypertension only
[13,14,20,24].Location/setting
Twelve of the 27 studies were undertaken in the United
States [10,12,15,16,18,19,22,23,26,30,31,33] and six in
Canada [9,11,17,25,29,32]. The remaining nine were
conducted in the UK [14,34], Hong Kong [27], India
[20], Italy [35], Korea [24], Nigeria [13], Spain [21], and
Turkey [28].
Participants were typically recruited in outpatient
clinics or hospital settings. Six of the 27 studies used na-
tional survey data [9,11,12,22-24].Sample size
Sample sizes ranged from 65 [21] to 10572 [12]. The
two largest studies were the US National Health Inter-
view Survey [12], and a survey of chelation in 5,854 cor-
onary angiography patients in Canada [11].Data collection
In these studies, research methods used for data collec-
tion included standardised, self administered surveys
[11,14,18,19,21,26,29,32,34] and face-to-face interviews
using a structured [12,24,25,31] or semi-structured in-
strument [10,13,16,20,27,28,35]. The remaining studies
used mixed methods, either a combination of face-to-face
and phone interview [15,30], face-to-face interview and
a medical examination [23], data collection from med-
ical records, [22,33] or a phone interview and informa-
tion from medical records [9]. One study used phone
interview alone [17].
Table 3 Characteristics of studies
Author (Year) Mode of data collection Sample
size
Diagnosis CAM Modalities Investigated Prevalence* (%)
Ackman et al. (1999) Standardised, self-administered survey 180 CHF Vitamins/minerals, nutritional supplements, health
food or herbal products; OTC medication
59^




Relaxation, spiritual healing, herbal medicine,
megavitamins, acupuncture, chiropractic, massage,
biofeedback, hypnosis, imagery, homeopathy; includes exercise.
80.9
Albert et al. (2009) Structured telephone or face-to-face interview 374 Heart failure Vitamins, minerals, herbal products, OTC medication 11.5^^
Amira & Okubadejo
(2007)
Semi-structured interview (face-to-face) 225 Hypertension NIH Categories: whole medical systems, mind-body therapies;
dietary supplements & herbs; energy therapy and manipulation
& touch therapy; plus sub-categories.
39.1
Artz et al. (2006) Combination of standardised survey
(face-to-face) and medical records
315 CVD Non-vitamin/mineral dietary supplement, vitamin/mineral
dietary supplement.
4
Barraco et al. (2005) Semi-structured face-to-face interview 223 CAD Folk remedies, herbal therapy, homeopathy, megavitamin
therapy (not daily vitamin), minerals (not calcium or iron),
native American medicine, Tibetan medicine, traditional Chinese




Standardised telephone survey 136 Stroke or
subarachnoid
haemorrhage
Acupuncture, massage, chiropractic, reflexology, magnetic
therapy, hyperbaric oxygen, herbal supplements, vitamins,
spiritual healing, reiki, chelation, relaxation
26.5
Buettner et al. (2007) Combination of standardised survey
(face-to-face) and medical examination;
part of the annual National Health and
Nutrition Examination Survey (NHANES)
1066 CAD or Stroke Vitamins, minerals, other dietary supplements 61
Chagan et al. (2005) Structured face-to-face interview 198 CVD Biologically based therapies (herbal medicine, Vitamins & minerals) 42
Dal Corso et al. (2007) Semi-structured face-to-face interview 153 CHF Herbal remedies, integrators (vitamins, minerals, salts), OTC medications 30^
Decker et al. (2007) Combination of face-to-face interview,
and medical records.
596 CAD Biofeedback, acupuncture, relaxation therapy, home remedies,
and chelation therapy
19
Gohar et al. (2008) Standardised, self administered survey 153 Hypertension NIH Categories: whole medical systems, mind-body
therapies; dietary supplements & herbs; energy therapy and manipulation
& touch therapy; (includes prayer)
37.9
Greenfield et al. (2008) Standardised, self administered survey; 422 CVD Open ended question on CAM; vitamins & minerals,
exercise, acupuncture, homeopathy, chiropractic, massage
9.2
Krasuski et al. (2006) Standardised, self administered survey 210 CVD Herbal medications, vitamin supplements (unless prescribed),
dietary supplements, visits to alternative medicine providers
54
Lee and Kim (2009) Structured face-to-face interviews 1434 Hypertension Dietary supplements 23.7
Leung et al. (2008) Standardised, self administered survey (mail out) 661 CAD Mind-body therapy: meditation, yoga, qigong, tai chi, relaxation
techniques, deep breathing exercise, visualisation, guided imagery, quiet
sitting, mantra, muscle relaxation, and other (not including prayer)
35.1
Liu et al. (2000) Standardised, self administered survey 263 Cardiac surgery Ayurveda, Acupuncture, Biofeedback, Chelation, Chiropractic,
Energy healing, guided imagery, Herbs, Homeopathy, Hypnosis, Massage
therapy, Meditation/relaxation, Naturopathy, Nutritional therapy, Prayer/pastoral





















Table 3 Characteristics of studies (Continued)
Martinez-Selles
et al. (2004)
Standardised, self administered survey 65 CHF CAM use was asked in the context of “use of over the counter
drugs and alternative medicine”
12
Pharand et al. (2003) Structured face-to-face interviews 306 CVD Vitamins or mineral products, nutritional supplements, health food or
herbal products (home remedies, oriental remedies)
22.9^
Quan et al. (2001) Standardised, self administered survey 5854 CAD Chelation therapy 7.9
Shafiq et al. (2003) Structured structured face-to-face interviews 521 Hypertension Ayurvedic medicine, herbal medicine, homeopathy, spiritual healing,
diet therapy and acupuncture
63.9
Stys et al. (2004) Physician interview 187 CVD Vitamin, mineral or herbal supplements 57
Wong et al. (2003) Physician interview 107 CVD Herbal medicine 26
Wood et al. (2003) Combination of structured phone interview,
medical records as part of a larger study: Improving
Cardiovascular Health in Nova Scotia (ICONS)
107 CVD Megavitamins, Herbal therapy, Other nutritional supplements,
Chiropractic, Massage therapy, Acupuncture, Homeopathy, Folk remedies,
Exercise, Energy healing, Chelation,Biofeedback, Relaxation therapy, Spiritual
healing, Hypnosis, Self-help groups (includes exercise)
64
*Yeh et al. (2006) Structured face-to-face interview; 2002
National Health Interview Survey
10572 CVD NIH Categories: whole medical systems, mind-body therapies; dietary supplements
& herbs; energy therapy and manipulation & touch therapy; (excluding prayer)
36
Yilmaz et al. (2007) Semi-structured face-to-face interview 310 CVD Herbal medicine 26.5
Zick et al. (2005) Standardised, self administered survey 252 CHF Herbs, vitamins, minerals, amino acids, other 32.5
* Refers to the prevalence reported in the study of the CAM modalities investigated.
^ No overall prevalence reported to the CAM, the figure presented here is for dictary supplement usage.





































Figure 2 Prevalence (%±95% confidence interval) of herbal
medicine use in people with CVDs.
Figure 1 Prevalence (%±95% confidence interval) of CAM
usage by people with CVDs.
Grant et al. BMC Public Health 2012, 12:299 Page 6 of 9
http://www.biomedcentral.com/1471-2458/12/299Study quality
The quality of the studies examined in the present re-
view varied significantly ranging from meeting only 25%
of the QAT criteria [21] to meeting more than 75% of
the QAT criteria [12]. Eight studies, representing 30% of
the total, scored less than 50% on the QAT (QAT ≤ 8/16)
[10,13,19,21,26,27,33-35]. Most studies clearly reported
the CAM modalities that were being assessed and pro-
vided a reasonable definition although the lists of CAM
modalities included in these definitions varied consider-
ably. The included studies were fairly diligent in their
collection of demographics (age, gender, ethnicity and
socioeconomic data) although some studies conducted
in regions or countries of more homogenous ethnicity
did not report ethnicity of the study population. Data
collection was commonly retrospective and the studies
were generally poor in their reporting of the frequency
and duration of CAM use, validation of the survey in-
strument, and providing a representative sample.
Prevalence of CAM use among CVD patients
The prevalence of CAM use among people with CVD
ranged from 4% [22] to 61% [23]. CAM modalities inves-
tigated were in some studies limited to types of bio-
logical-based therapies [10,21-24,26-29,31], a single
therapy such as mind-body therapy [32] or chelation
[11]. In the seven studies which used comprehensive
lists or definitions of CAM [12-14,17,18,20,33], preva-
lence of CAM usage ranged from 19% to 64%.
Six studies were excluded from Figure 1 as we could
not separate the use of exercise [9,15] and/or prayer
[13,16] from the overall CAM usage data. In the other
three studies [25,30,35], OTC medications or nutritional
supplements and health food could not be extracted
from the overall CAM figure.
Types of CAM modalities used
Biological based therapies Of the 23 studies that reported
on biologically-based therapies, only three provided an
overall prevalence figure and breakdown into herbal medi-
cine or dietary supplements [10,12,20]. Seven studies
[10,12,13,18,23,26,31] provided data on overall biologic-
ally-based therapies usage that ranged from 22% [12] to
68% [18]. Eight studies provided only separate figures for
herbal and/or dietary supplements and did not ascertain
an overall prevalence. Biologically-based therapies were
reported as an average of two supplements per user
[28,31] while another study recorded an average of three
supplements per user [10].
Herbal Medicine In sixteen studies reporting the
prevalence of herbal medicine use by people with CVD,
herbal medicines were used by between 2% [17] and 46%
[20] of respondents (Figure 2). Data for Zick (2005) was
not presented in Figure 2 as herbal medicine could notbe separated from vitamins and minerals. The top five
individual herbs utilised were echinacea (2% [26] to 14%
[30]), garlic (1% [28] to 69% [13]), ginger (1% [29] to
24% [13]), ginkgo (1% [26] to 9% [30]), and ginseng (1%
[25] to 6% [29]).
Vitamin, Minerals and Other Dietary Supplements
The thirteen studies that provided prevalence data on vita-
mins, minerals and other dietary supplements showed















Figure 3 Prevalence (%±95% confidence interval) of Vitamin
and Mineral Use in People with CVDs.
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common supplements were vitamin B/B12 or B complex,
vitamin C, vitamin E, calcium, glucosamine/chondroitin,
coenzyme Q10, calcium and magnesium.
Mind-body therapies Seven studies [12,14,15,17,19,32,33]
reported on the prevalence of mind-body therapy (MBT)
usage, which ranged from 2 to 57%. An additional study
[13], reported on the prevalence of mind-body connection
(3.4%) but this was limited to prayer and fasting. Deep
breathing and meditation were the most common MBT
therapies among the CVD participants. The main reasons
for MBT usage were for psychological and emotional well-
being.
Physician awareness of patients’ CAM use
Physician awareness of their patient’s CAM therapy use
was reported in six studies [12,16-18,28,31]. Awareness
was lowest in the Turkish study, 8% [28], and was between
39-65% in the others [12,16,18,31]. The reason for non-
disclosure to physicians about CAM use was investigated
in two studies. Reasons given were fear that their physician
might disapprove [17] and that their physician had not
enquired about their CAM use [16].
Reasons for CAM use
Twelve studies investigated CAM users’ perceptions
of CAM or reasons for CAM use [9,12,15-
18,20,26,30,31,34,35]. CAM was thought to be of greaterbenefit than conventional medications by 15% of users in
two studies [9,18]. One study reported that 59% of patients
chose CAM due to adverse drug reactions to conventional
therapy [20]. Overall well-being and promoting good
health were the main reasons given for taking vitamins
and herbal therapy in one study [30]. Two studies reported
that CAM was a perceived remedy by 40% [15] and 57%
[9] of users, and 28% reported that it had a proven benefit
for their condition [9].
The use of CAM specifically to treat cardiovascular
disease was reported in six studies [9,16,18,26,28,31]. In
patients with heart failure, up to 82% of CAM users
were taking a supplement specifically for cardiovascular
health [26]. Wood et al. (2003) and Chagan et al. (2005)
reported that 43% [9] and 65% [31] of CAM users used
CAM for their CVD, and in the remaining four studies,
between 7% [18] and 23% [16,28] had used CAM for
their CVDs.
Five studies reported that users of CAM felt that bio-
logically-based therapies were safe or had fewer side
effects than conventional medications [9,15,18,31,35].
This perception ranged from 29% to 45% of CAM users
in four of the five studies, and in the remaining study
3% of patients reported that the reason for using CAM
therapies was due to fewer side effects compared to con-
ventional treatment [9].
Concurrent use of biological-based therapies and
prescription medication
Seven studies reported data on the concomitant use of
prescription medication and biological- based therapies
[9,15,18,22,23,27,31]. Aggregation of data was difficult due
to variations in method although useful insights are pro-
vided by these investigations. On average, cardiovascular
patients consumed seven prescribed medications and two
herbal, vitamin or mineral products daily [9]. One study
undertook an examination of medical records and identi-
fied 42 potential herb-drug interactions [31]. Two studies
found that people with cardiovascular disease had taken
dietary supplements or herbal medicine with warfarin
[9,27]. In the Canadian study, 13% of patients had used a
dietary supplement in conjunction with warfarin, amiodar-
one, sotalol, or digoxin [9]. In the Hong Kong study, 26%
of patients on warfarin had taken a herbal medicine in the
week prior to interview [27]. Taking medication such as
aspirin, beta-blockers, ACE inhibitors, statins and warfarin
did not appear to alter the likelihood of using biological-
based therapies [18].
Compliance to prescribed medication was examined in
three studies [14,35,42]. The use of biological-based ther-
apies was found to not effect compliance to antihyperten-
sive medication, except in one study where females had
lower compliance [14]. In a study of outpatients with heart
failure taking herbal medicine reported that 1 in 22
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Discussion
The results indicate that CAM use is common in cardiac
patients but the prevalence of CAM use varies signifi-
cantly (4%-61%). The large range found is consistent with
other reviews in the CAM literature [2,43]. The findings
have strong implications for both clinical practice and re-
search in this field. The lack of specific and consistent
definitions of CAM in the reviewed studies contribute to
the variability observed and has made generalisations diffi-
cult. A standard and complete definition of CAM use
would facilitate meta-analysis in future studies [43].
The reasons for CAM use vary remarkably between
different cohorts although six studies did find that
patients used CAM specifically for the management of
their CVDs. Although our review has found inconsistent
results with regard to the association between CAM use
and compliance, some evidence exists to suggest that
CAM use may affect the compliance of prescription
medicines [14,35]. A patients’ belief that their CAM
usage help manage their CVD may give them a false
sense of security that may lead to a reduction of their
concurrently medicines.
We found across the studies that patients with CVD are
likely to be using more than one CAM product simultan-
eously [9,10,23,28,31]. There appeared to be little aware-
ness that there may be interactions with their prescription
medication, having potential additive or negative effects
on the therapeutic levels of their medication or a harmful
adverse effect [28,31,35]. Supplemental potassium was
taken by 20% of patients in one study [29], which can re-
sult in adverse outcomes when used together with com-
monly prescribed medications such as angiotensin
converting enzyme inhibitors, aldosterone receptor
antagonists, or angiotensin receptor blockers. The poten-
tial effects and implications of herb-drug interaction with
CVD medications have been discussed in detail elsewhere
[44,45].
It is of great concern that a large proportion of med-
ical practitioners (35 - 92%) were unaware of the CAM
use by their patients [12,16-18,28,31]. Although patients
may be reluctant to disclose CAM use because they fear
disapproval, doctors also do not appear to be asking
their patients about CAM use [31].
The results of our review are restricted in several
aspects. For example, the quality of the reviewed studies
was highly variable. Data collection in most of the studies
was retrospective. This led to high variability in the result-
ing prevalence rates and may have introduced significant
recall bias. Many studies also lacked the use of a validated
survey, a representative sample, and rarely did the study
authors address potential biases arising from theirmethods. Many of the studies failed to report the fre-
quency and duration of CAM use. Several studies made
use of clinical samples, but few provided objective data on
the health status of the patients. The results presented
here should therefore be treated with caution. We were
only able to include studies published in the English lan-
guage and therefore the findings have limited generalis-
ability outside of English-speaking regions. However we
note that it is within countries such as Australia and the
United States where use and concerns about CAM are
growing the fastest. Therefore the current study provides
much needed information on these areas.
Conclusions
The use of CAM is common in patients with cardiovas-
cular conditions. A high proportion of patients using
CAM believe CAM has remedial benefits, and were at
least as safe as or safer than their prescribed treatments.
CVD patients were often unwilling to inform their med-
ical practitioners of CAM use. Many commonly used
CAM products have the potential to interfere with the
intended action of prescription medications. In addition,
the CAM use may have negative impacts on the compli-
ance with prescription medications. Better education of
patients, medical practitioners and pharmacists is
needed to improve understanding of the risks and bene-
fits of CAM use. Future studies are required to deter-
mine the impacts of CAM use in CVD patients,
particularly its clinical and prognostic impact when used
in conjunction with prescription medicines.
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